We consider identifying differentially expressing genes between two patient groups using microarray experiment. We propose a sample size calculation method for a specified number of true rejections while controlling the false discovery rate at a desired level. Input parameters for the sample size calculation include the allocation proportion in each group, the number of genes in each array, the number of differentially expressing genes, and the effect sizes among the differentially expressing genes.
INTRODUCTION
Microarray method has been widely used for identifying differentially expressing genes, called prognostic genes, in the subjects with different types of disease. Statistical procedures to identify differentially expressing genes involve a serious multiple comparison problem since we perform as many hypothesis testings as the number of the candidate genes in microarrays. If we use a type I error rate α in each testing, then the probability to reject any hypothesis will greatly exceed the intended overall α level. In order to avoid this pitfall, two approaches are widely used: false discovery rate (FDR) control and family-wise error rate (FWER) control.
Sample size calculation is a critical procedure when designing a microarray study.
There have been several publications on sample size estimation in the microarray context, e.g. Simon et al. (2002) . Some focused on exploratory and approximate relationships among statistical power, sample size (or the number of replicates) and effect size (often, in terms of fold-change), and used the most conservative Bonferroni adjustment for controlling FWER (the probability to discover one or more genes when none of the genes under consideration are prognostic) without any attempt to incorporate the underlying correlation structure (Wolfinger et al., 2001; Black and Doerge, 2002; Pan et al., 2002; Cui and Churchill, 2003) . Jung et al. (2005) incorporated the correlation structure to derive an accurate sample size when controlling the FWER.
Some researchers proposed a new concept of testing error called false discovery rate (FDR), defined as the expected value of the proportion of the non-prognostic genes among the discovered genes (Benjamini and Hochberg, 1995; Storey, 2002) .
Controlling this quantity relaxes the multiple testing criteria compared to controlling the FWER in general, and consequently increases the number of declared significant genes. Operating and numerical characteristics of FDR are elucidated in recent publications (Genovese and Wasserman, 2002; Dudoit et al., 2003) . Lee and Whitmore (2002) considered multiple group cases, including the 2-sample case, using ANOVA models and derived the relation between the effect sizes and the FDR based on a Bayesian perspective. They discuss a power analysis without involving the multiple testing issue. Müller et al. (2004) chose a pair of testing errors, including FDR, and minimized one while controlling the other at a specified level using a Bayesian decision rule. They proposed a simulation algorithm to demonstrate the relationship between sample size and the chosen testing errors based on asymptotic results. This approach requires specification of complicated parametric models for prior and data distributions, and extensive computing for the Baysian simulations.
Most of the existing studies for FDR-control do not show the explicit relationship between sample size and effect sizes because of different reasons. For example, Lee and Whitmore (2002) and Gadbury et al. (2004) modelled a distribution of p-values from pilot studies to produce sample size estimates but did not provide an explicit sample size formula. None of the aforementioned studies based on FDR evaluated their sample sizes using simulations.
In this paper, we propose a sample size estimation procedure for FDR-control.
We derive the sample size required for a specified number of true rejections (i.e., identifying the prognostic genes) while controlling the FDR at a desired level. As input parameters, we specify the allocation proportions between two groups, the total number of candidate genes, the number of prognostic genes, the effect sizes of the prognostic genes in addition to the required number of true rejections and the FDR level. In general, our procedure requires solving an equation using a numerical method such as the bisection method. However, if the effect sizes are equal among all prognostic genes, the equation can be solved to give a closed form formula. We review the background of FDR and its estimation method in Section 2, and propose a new sample size method in Section 3. In Section 4, we discuss simulation studies that are conducted to show that the calculated sample sizes are accurate, and demonstrate an application of our method to a real study. van den Oord and Sullivan (2003) considered a similar setting for sample size calculation, but their formulation is so general that they do not provide an explicit formula in any specific case.
FALSE DISCOVERY RATE
Suppose that we conduct m multiple tests, of which the null hypotheses are true for m 0 tests and the alternative hypotheses are true for m 1 (= m − m 0 ) tests. The tests declare that, of the m 0 null hypotheses, A 0 hypotheses are null (true negative) and R 0 hypotheses are alternative (false rejection, false discovery or false positive).
Among the m 1 alternative hypotheses, A 1 are declared null (false negative) and R 0 are declared alternative (true rejection, true discovery or true positive). Table 1 summarizes the outcome of m hypothesis tests. (Table 1 may be placed around here.) Benjamini and Hochberg (1995) define the FDR as
Note that this expression is undefined if Pr(R = 0) > 0. To avoid this issue, Benjamini and Hochberg (1995) redefine the FDR as
These two definitions are identical if Pr(R = 0) = 0, in which case we have FDR = E(R 0 /R|R > 0) (≡ pFDR, which will be defined below).
If m = m 0 , then FDR=1 by any critical value with Pr(R = 0) = 0. Pointing out this issue, Storey (2003) defines the second factor in the right hand side of (2) as pFDR,
and proposes to control this quantity instead of FDR. Storey (2002) claims that Pr(R > 0) ≈ 1 with a large m, so that pFDR is equivalent to FDR. We accept this argument in this paper and do not distinguish between FDR and pFDR. Hence, definitions (1) and (2) are considered to be equal. We observed R > 0 in all of the simulations conducted in Section 4. Benjamini and Hochberg (1995) propose a multi-step procedure to control the FDR at a specified level. However this is known to be conservative, and the conservativeness increases in m 0 , see, e.g., Storey et al. (2004) .
Suppose that, in the j-th testing, we reject the null hypothesis H j if the p-value p j is smaller than or equal to α ∈ (0, 1). Assuming independence of the m p-values, we have
which equals m 0 α, where m −1 o p (m) → 0 in probability as m → ∞ (Storey, 2002) .
Ignoring the error term, we have
where 
By combining this m 0 estimator with (3), Storey (2002) obtains
For an observed p-value p j , Storey (2002) defines the q-value, the minimum FDR level at which we reject H j , as
This formula is reduced to
if FDR(α) is strictly increasing in α, see Theorem 2 of Storey (2003) . Appendix shows that this assumption holds if the power function of the individual tests is concave in α, which is the case when the test statistics follow the standard normal distribution under the null hypotheses. We reject H j (or, equivalently, discover gene j) if q j is smaller than or equal to the prespecified FDR level.
The independence assumption among m test statistics was loosened to independence only among m 0 test statistics corresponding to the null hypotheses by Storey and Tibshirani (2001) , and to weak independence among all m test statistics by Storey (2003) and Story et al. (2004) . These approaches are implemented in the statistical package called SAM, see Storey and Tibshirani (2003) .
SAMPLE SIZE CALCULATION
Let M 0 and M 1 denote the set of genes for which the null and alternative hypotheses are true, respectively. Note that the cardinalities of M 0 and M 1 are m 0 and m 1 , respectively. Since the estimated FDR is invariant to the order of the genes, we may rearrange the genes and set M 1 = {1, ..., m 1 } and M 0 = {m 1 + 1, ..., m}.
By Storey (2002) and Storey and Tibshirani (2001) , for large m and under independence (or weak dependence) among the test statistics, we have
power of the single α-test applied to gene j ∈ M 1 . So, from (3), we have
by omitting the error term.
Let X ij (Y ij ) denote the expression level of gene j for subject i in group 1 (and group 2, respectively) with common variance σ 2 j . We consider two-sample t-tests,
for hypothesis j (= 1, .., m), where n k is the number of subjects in group k(= 1, 2),X j andȲ j are sample means of {X ij , i = 1, ..., n 1 } and {Y ij , i = 1, ..., n 2 }, respectively, andσ 2 j is the pooled sample variance. We assume a large sample (i.e. n k → ∞), so that T j ∼ N (0, 1) for j ∈ M 0 . Let n = n 1 + n 2 denote the total sample size, and a k = n k /n the allocation proportion for group k. Let δ j denote the effect size for gene j in the fraction of its standard error, i.e.
At the moment, we consider one-sided tests, H j : δ j = 0 againstH j : δ j > 0, by assuming δ j > 0 for j ∈ M 1 and δ j = 0 for j ∈ M 0 . The two-sided testing case is briefly discussed at the end of this section. Note that, for large n,
for j ∈ M 1 , so that we have
whereΦ(·) denotes the survivor function and z α =Φ −1 (α) is the upper 100α-th percentile of N (0, 1). Hence, (4) is expressed as
From (5) we want to find the sample size n that will guarantee a certain number, say r 1 (≤ m 1 ), of true rejections with FDR controlled at a specified level f .
In (5), the expected number of true rejections is
In multiple testing controlling FDR, E(R 1 )/m 1 plays the role of the power of a conventional testing, see Lee and Whitmore (2002) and van den Oord and Sullivan (2003) .
With E(R 1 ) and the FDR level set at r 1 and f , respectively, (5) is expressed as
By solving this equation with respect to α, we obtain
.
Given m 0 , α * is the marginal type I error level for r 1 true rejections with the FDR controlled at f . With α and E(R 1 ) replaced by α * and r 1 , respectively, (6) yields an equation h(n) = 0, where
We obtain the sample size by solving this equation. In general, solving the equation h(n) = 0 requires a numerical approach, such as the bisection method:
(a) Choose s 1 and s 2 such that 0 < s 1 < s 2 and h 1 h 2 < 0, where
(c) If h 1 h 3 < 0, then replace s 2 and h 2 with s 3 and h 3 , respectively. Else, replace s 1 and h 1 with s 3 and h 3 , respectively. Go to (b). If we do not have prior information on the effect sizes, we may want to assume equal effect sizes δ j = δ (> 0) for j ∈ M 1 . In this case, (7) is reduced to
and, by solving h(n) = 0, we obtain a closed form formula:
where α * = r 1 f /{m 0 (1 − f )} and β * = 1 − r 1 /m 1 . Note that (8) is the conventional sample size formula when we want to detect an effect size of δ with power 1 − β * while controlling the type I error level at α * .
In summary, our sample size calculation proceeds as follows.
(A) Specify the input parameters: 
where α * = r 1 f /{m 0 (1 − f )} and β * = 1 − r 1 /m 1 .
2. Otherwise, solve h(n) = 0 using the bisection method, where
Given sample sizes n 1 and n 2 , one may want to check how many true rejections are expected as if we want to check the power in a conventional testing. In this case,
we solve the equations for r 1 . For example, when the effect sizes are constant, δ j = δ for j ∈ M 1 , we solve the equation
with respect to r 1 , where α * (r 1 ) = r 1 f /{m 0 (1 − f )} and β * (r 1 ) = 1 − r 1 /m 1 . and z α * = 3.841, so that we have h(n) = 20Φ(3.841 − n/4) + 20Φ(3.841 − .5 n/4) − 24 Table 2 displays the bisection procedure with starting values s 1 = 100 and s 2 = 200.
The procedure stops after 7 iterations and gives n = [147.7] + 1 = 148.
( Table 2 may be placed around here.)
Two-Sided Tests
Suppose one wants to test H j : δ j = 0 againstH j : δ j = 0. We reject
for a certain α level, and obtain the power function ξ j (α) =Φ(z α/2 − |δ j | √ na 1 a 2 ). In this case, α * is the same as that for one-sided test case, i.e.
If the effect sizes are constant, i.e. δ j = δ for j ∈ M 1 , then we have a closed form
where α * = r 1 f /{m 0 (1 − f )} and β * = 1 − r 1 /m 1 . Now we derive the relationship between the sample size for one-sided test case and that for two-sided test case. Suppose that the input parameters m, m 1 , a 1 and {δ j , j ∈ M 1 } are fixed and we want r 1 true rejections in both cases. Without loss of generality, we assume that the effect sizes are nonnegative. The only difference between the two cases is the parts of α * in (7) and α * /2 in (9). Let f 1 and f 2 denote the FDR levels for one-and two-sided testing cases, respectively. Then, the two formulas will give exactly the same sample size as far as these two parts are identical,
which yields f 1 = f 2 /(2 − f 2 ). In other words, with all other parameters fixed, the sample size for two-sided tests to control the FDR at f can be obtained using the sample size formula for one-sided tests (7) by setting the target FDR level at f /(2−f ).
Note that this value is slightly larger than f /2. The same relationship holds when the effect sizes for prognostic genes are constant. By the above argument, we obtain exactly the same sample size using formula (8) and f = .01/(2 − .01) = 0.005025. Note that this sample size is slightly larger than n = 68 which was obtained for one-sided tests in Example 1.
Exact Formula based on t-Distribution
If the gene expression level, or its transformation, is a normal random variable and the available resources are so limited that only a small sample size can be considered, then one may want to use the exact formula based on t-distributions, rather than that based on normal approximation. In one-sided testing case, (5) will be modified to
where T ν,η (t) is the survivor function for the non-central t-distribution with ν degrees of freedom and non-centrality parameter η, and t ν,α = T −1 ν,0 (α) is the upper 100α-th percentile of the central t-distribution with ν degrees of freedom. The required sample size n for r 1 true rejections with the FDR controlled at f solves h T (n) = 0, where
and α * = r 1 f /{m 0 (1 − f )}. If the effect sizes are constant among the prognostic genes, then the equation reduces to T n−2,δ √ na 1 a 2 (t n−2,α * ) = r 1 /m 1 , but, contrary to the normal approximation case, we do not have a closed form sample size formula since n is included in both the degrees of freedom and the non-centrality parameter of the t-distribution functions.
Similarly, the sample size for two-sided t-tests can be obtained by solving h T (n) = 0, where
and α * = r 1 f /{m 0 (1 − f )}. Note that the sample size for FDR = f with two-sided testings is the same as that for FDR = f /(2 − f ) with one-sided testings as in the testing based on normal approximation.
NUMERICAL STUDIES
In order to investigate the accuracy of the proposed sample size formula, we conducted extensive simulation studies. We set m = 4000, m 1 = 40 or 200, constant effect sizes δ = 0.5 or 1, and a 1 = 0.5 or 0.7. We want r 1 to be 30%, 60% or 90% of m 1 while controlling the FDR level at f = 1%, 5% or 10% using one-sided p-values.
Given a design setting, we first calculate the sample size n using formula (8) which is based on normal approximation, and then generate N = 5000 samples of size n from independent normal distributions under the same setting. From each simulation sample, the number of true rejections are counted while controlling the FDR at the specified level using the Storey's approach discussed in Section 2 with λ = 0.5. The first, second and third quartiles, Q 1 , Q 2 and Q 3 , of the observed true rejections,r 1 , are estimated from the 5000 simulation samples. Table 3 reports n and the three quartiles ofr 1 for each design setting. We observe that n increases in |a 1 − 1/2| and r 1 , and decreases in δ and FDR. The median, Q 2 , ofr 1 is close to the nominal r 1 overall except when (a 1 , m 1 , δ, r 1 ) = (0. 5, 200, 1, 60) or (0.7, 200, 1, 60) , for which n is relatively small and r 1 tends to be overestimated. With a large n, r 1 is very accurately estimated, i.e. Q 2 is close to r 1 and the inter-quartile range (Q 3 − Q 1 ) is small. The interquartile range ofr increases in r 1 , but does not seem to be much dependent on the FDR level.
( Table 3 may Now, we consider a case where we have pilot data. Golub et al. (1999) explored m = 6810 genes extracted from bone marrow in n = 38 patients, of which n 1 = 27 with acute lymphoblastic leukemia and n 2 = 11 with acute myeloid leukemia, in order to identify the susceptible genes with potential clinical heterogeneity in the two subclasses of leukemia. Suppose that we use the data set from this study as pilot data in designing a new study with the same study objective. For gene j(= 1, ..., 6810),
we calculated the sample meansx j ,ȳ j and the sample variances
and estimated the effect sizesδ
from the pilot data. In order to reflect the variability of the estimated effect sizes and for a slightly conservative sample size, we multiply 0.6 to the observed effect sizes, i.e. δ j = 0.6|δ j |, in the following sample size calculation. We assume that the top m 1 = 50 genes with the largest effect sizes in absolute value are prognostic. Suppose that we want to identify 60% of the prognostic genes, i.e. r 1 = 0.6 × 50 = 30, while controlling the FDR at f = 1% level using two-sided p-values. Based on the pilot data, we set a 1 = .7(≈ 27/38) and m = 7000. In this case, we have
so that z α * /2 = 4.088. From (9), we solve
using the bisection method, and obtain n = 58, or (n 1 , n 2 ) ≈ (41, 17). We generated 5000 simulation samples of size n = 58 under the design setting, and observed the quartiles Q 2 (Q 1 , Q 3 ) = 30(28, 33) from the empirical distribution of the observed true rejections. Note that the median Q 2 exactly matches the projected r 1 in this case. Table 4 reports the sample sizes under different settings: m 1 = 50 or 100; r 1 /m 1 = 0.3 or 0.6; FDR = 1%, 5% or 10%.
( Table 4 may be placed around here.)
A referee raised a question about the accuracy of our sample size estimate when the gene expression data are correlated or have other distributions than normal distributions. In order to address this issue, we at first consider normal gene expression data with a block compound symmetry (CS) correlation structure: there are 400 independent blocks, and each block consists of 10 dependent genes with a CS structure and correlation coefficient ρ = 0.6. The first half of Table 5 reports the distribution of the empirical true rejections under (a 1 , m 1 , δ) = (0.5, 40, 1) and r 1 = 12 or 24. We assume that the prognostic genes belong to the first 4 blocks. Note that the estimated sample sizes are given in Table 3 under the same design settings. From Table 5 , we observe that the median Q 2 of the observed true rejections is close to the nominal r 1 as in the independent data case. However, the inter-quartile range is almost doubled from that under independence, from about 5 to about 10. In the second set of simulations, we generate gene expression data from a correlated asymmetric distribution:
for b = 1, ..., 400 and 10(b − 1) + 1 ≤ j ≤ 10b,
where ρ = 0.6 and e k,1 , ..., e k,4000 , k,1 , ..., k,400 are i.i.d. random variables from the χ 2 distribution with 2 degrees of freedom. Note that both (X 1 , ..., X m ) and (Y 1 , ..., Y m ) have marginal variances 1, and the same block CS correlation structure as in the above correlated normal data case. The second half of Table 5 reports the simulation results. We observe almost the same results as in the correlated normal data case.
Benjamini and Yekutieli (2001) investigate general distributional assumptions for the control of FDR.
( Table 5 may be placed around here.)
DISCUSSION
Microarray has been a major high-throughput assay method to display DNA or RNA abundance for a large number of genes concurrently. Discovery of the prognostic genes should be made taking multiplicity into account, but also with enough statistical power to identify important genes successfully. Due to the costly nature of microarray experiments, however, often only a small sample size is available and the resulting data analysis does not give reliable answers to the investigators. If the findings from a small study look promising, a large scale study may be developed to confirm the findings using appropriate statistical tools. Our sample size formula will play the role in the design stage of such a confirmatory study. It can be used to check the statistical power, r 1 /m 1 , of a small scale pilot study too.
The proposed method is to calculate the sample size for a specified number of true rejections (or the expected number of true rejections given a sample size) while controlling the FDR at a given level. The input variables to be pre-specified are total number of genes for testing m, projected number of prognostic genes m 1 , allocation proportions a k between groups, and effect sizes for the prognostic genes. The method does not require any heavy computation, such as Monte Carlo simulations, so that we get a sample size in a second. Especially, if the effect sizes among the prognostic genes are the same, we have a closed form formula that can be calculated using a scientific calculator and a normal distribution table. The proposed method can be used to design a new study based on the parameter values estimated from pilot data.
It is shown through simulations that the formula based on normal approximation works well overall, even when the expression levels are weakly correlated or have skewed distributions. If there exists dependency among the genes, the observed number of true rejections tends to have a wide variation around the nominal r 1 . The computer program for sample size calculation available from the author.
APPENDIX
With the other parameters fixed, FDR is increasing in α.
Proof: It suffices to show that, for j ∈ M 1 , g(α) = ξ j (α)/α is decreasing in α, or
} is negative for all α ∈ (0, 1). Note that the latter condition holds if ξ j (α) is concave in α.
In this appendix, we assume that the test statistics follow the standard normal distribution under the null hypotheses. Let φ(z) = 1/ √ 2π exp(−z 2 /2) andΦ(z) = ∞ z φ(t)dt denote the probability density function and the survivor function of the standard normal distribution, respectively. Noting that
and z α =Φ −1 (α), we have
Showing g (α) < 0 is equivalent to showing
which holds since δ j > 0 and φ(z)/Φ(z) is an increasing function by the following lemma.
Lemma: φ(z)/Φ(z) is an increasing function.
Proof: Let's show that Table 2 . The bisection procedure for Example 2.
Step Table 3 . Sample size n for r 1 (=30%, 60% or 90% of m 1 ) true rejections at FDR=1%, 5% or 10% level by one-sided tests when m = 4000, m 1 = 40 or 200, δ = 0.5 or 1, a 1 = 0.5 or 0.7. Each cell consists of Q 2 (Q 1 , Q 3 )/n, where n is the required sample size, and Q 1 ,Q 2 and Q 3 are the first, second and third, respectively, quartiles of the observed number of true rejections from 5000 simulations. Table 4 . Sample size n for r 1 (=30% or 60% of m 1 ) true rejections at FDR=1%, 5% or 10% level by two-sided p-values when m = 7000, m 1 = 50 or 100, a 1 = .7. The effect sizes are estimated from Golub et al. (1999) Table 5 . Simulation results from normal or mixture of χ 2 2 distributions with 400 independent blocks and CS correlation structure with ρ = 0.6 within each block of size 10. Other parameters are set at (a 1 , m 1 , δ) = (0.5, 40, 1) and r 1 = 12 or 24.
Each cell consists of Q 2 (Q 1 , Q 3 ), the quartiles of the observed number of true rejections from 5000 simulations. The sample sizes are given in Table 3 
